We are live on ! Find out more
DC

Davenport & Co Portfolio holdings

AUM $20.4B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
-0.4%
1 Year Est. Return
+18.11%
3 Year Est. Return
+63.26%
5 Year Est. Return
+74.4%
10 Year Est. Return
+287.26%
AUM
$17.2B
AUM Growth
-$464M
Cap. Flow
-$128M
Cap. Flow %
-0.74%
Top 10 Hldgs %
18.43%
Holding
1,236
New
87
Increased
599
Reduced
401
Closed
67

Sector Composition

Rank Sector Weight
1 Financials 17.44%
2 Technology 13.25%
3 Healthcare 12.44%
4 Consumer Discretionary 10.52%
5 Industrials 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTR icon
1026
Ventas
VTR
$46.6B
$276K ﹤0.01%
+4,014
New +$256K
FXL icon
1027
First Trust Technology AlphaDEX Fund
FXL
$2.63B
$276K ﹤0.01%
2,085
PSF icon
1028
Cohen & Steers Select Preferred & Income Fund
PSF
$234M
$275K ﹤0.01%
13,744
+45
+0.3% +$905
PPLT
1029
abrdn Physical Platinum Shares ETF
PPLT
$1.88B
$274K ﹤0.01%
30,000
XLG icon
1030
Invesco S&P 500 Top 50 ETF
XLG
$10.8B
$273K ﹤0.01%
5,942
+134
+2% +$6.61K
VDC icon
1031
Vanguard Consumer Staples ETF
VDC
$7.95B
$273K ﹤0.01%
1,245
-6
-0.5% -$1.3K
PDI icon
1032
PIMCO Dynamic Income Fund
PDI
$7.35B
$272K ﹤0.01%
13,748
-31,799
-70% -$619K
VFH icon
1033
Vanguard Financials ETF
VFH
$13.6B
$272K ﹤0.01%
2,274
-500
-18% -$60.9K
SPYV icon
1034
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.4B
$272K ﹤0.01%
5,317
+39
+0.7% +$2.02K
REGN icon
1035
Regeneron Pharmaceuticals
REGN
$78.2B
$271K ﹤0.01%
+427
New +$294K
IJS icon
1036
iShares S&P Small-Cap 600 Value ETF
IJS
$8.28B
$271K ﹤0.01%
2,777
-168
-6% -$17.7K
CR icon
1037
Crane Co
CR
$12.7B
$268K ﹤0.01%
1,750
NUEM icon
1038
Nuveen ESG Emerging Markets Equity ETF
NUEM
$372M
$267K ﹤0.01%
9,143
+188
+2% +$5.55K
NVG icon
1039
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.66B
$266K ﹤0.01%
21,513
+75
+0.3% +$940
HYG icon
1040
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$266K ﹤0.01%
+3,376
New +$268K
NU icon
1041
Nu Holdings
NU
$69.8B
$266K ﹤0.01%
26,000
+500
+2% +$5.91K
JRI icon
1042
Nuveen Real Asset Income & Growth Fund
JRI
$352M
$265K ﹤0.01%
20,509
-9,066
-31% -$115K
SNAP icon
1043
Snap
SNAP
$8.48B
$265K ﹤0.01%
30,400
+5,000
+20% +$52.1K
SPHY icon
1044
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.6B
$265K ﹤0.01%
+11,300
New +$267K
CHE icon
1045
Chemed
CHE
$7.07B
$265K ﹤0.01%
+430
New +$244K
DGX icon
1046
Quest Diagnostics
DGX
$25.6B
$264K ﹤0.01%
+1,560
New +$256K
OLLI icon
1047
Ollie's Bargain Outlet
OLLI
$4.51B
$264K ﹤0.01%
2,266
+217
+11% +$22.9K
BSCT icon
1048
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
$2.91B
$263K ﹤0.01%
14,167
+11
+0.1% +$203
LONZ icon
1049
PIMCO Senior Loan Active Exchange-Traded Fund
LONZ
$581M
$262K ﹤0.01%
5,205
-1,661
-24% -$84.4K
FIXD icon
1050
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.23B
$262K ﹤0.01%
5,978
+458
+8% +$19.9K

Similar funds

Davenport & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Davenport & Co held 1,236 positions worth $17.2B, down 2.6% from $17.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Davenport & Co's Q1 2025 filing shows 87 new, 599 increased, 401 reduced and 67 closed positions. Its largest new stake was Wynn Resorts: 595,236 shares worth $49.5M. The largest sale was Air Products & Chemicals, an estimated $161M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Davenport & Co's largest Q1 2025 buy was Wynn Resorts: 595,236 shares worth $49.5M.
  • Davenport & Co added most to Caesars Entertainment in Q1 2025, an estimated $104M increase.
  • Davenport & Co's biggest Q1 2025 reduction was Air Products & Chemicals, cutting an estimated $161M.
  • Davenport & Co fully exited Maximus in Q1 2025, selling an estimated $2.97M.
  • Davenport & Co's ten largest holdings make up 18% of its $17.2B portfolio in Q1 2025.
  • Davenport & Co opened 87 new positions and closed 67 in Q1 2025.
  • Davenport & Co's portfolio value fell 2.6% quarter-over-quarter to $17.2B.

Based on Davenport & Co's 13F filing for Q1 2025, filed 28 Apr 2025.